주식/증권 ➡️ 중립 Co-Diagnostics anticipates filing FDA 510(k) in the third quarter as CoSara expands TAM to approximately $13B Seeking Alpha - Market News 05/14/2026 11:12:14 PM 52회 원문 기사 보기